LHC Group (NASDAQ:LHCG) COO Donald Dwayne Stelly sold 2,650 shares of the firm’s stock in a transaction that occurred on Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the transaction, the chief operating officer now owns 109,235 shares of the company’s stock, valued at $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Shares of LHC Group (NASDAQ:LHCG) traded down 0.02% during midday trading on Friday, reaching $65.42. 136,701 shares of the company’s stock traded hands. The stock’s 50-day moving average price is $62.90 and its 200 day moving average price is $59.03. LHC Group has a one year low of $32.04 and a one year high of $69.35. The firm has a market capitalization of $1.20 billion, a PE ratio of 28.95 and a beta of 0.76.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.09. The business had revenue of $260.20 million during the quarter, compared to the consensus estimate of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The firm’s revenue for the quarter was up 15.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.52 EPS. On average, equities research analysts expect that LHC Group will post $2.39 earnings per share for the current fiscal year.

WARNING: “Insider Selling: LHC Group (LHCG) COO Sells 2,650 Shares of Stock” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/09/08/insider-selling-lhc-group-lhcg-coo-sells-2650-shares-of-stock.html.

LHCG has been the subject of several research analyst reports. Jefferies Group LLC lifted their target price on shares of LHC Group from $56.00 to $65.00 and gave the company a “buy” rating in a research report on Monday, May 15th. Royal Bank Of Canada reiterated a “buy” rating and set a $69.00 target price on shares of LHC Group in a research report on Monday, May 15th. Benchmark Co. lifted their target price on shares of LHC Group from $63.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, June 8th. Zacks Investment Research lowered shares of LHC Group from a “buy” rating to a “hold” rating in a research report on Thursday, July 6th. Finally, BidaskClub lowered shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 12th. Ten equities research analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and a consensus price target of $67.00.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Federated Investors Inc. PA boosted its position in shares of LHC Group by 4.2% during the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after acquiring an additional 66 shares during the last quarter. Acrospire Investment Management LLC boosted its position in shares of LHC Group by 30.8% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after acquiring an additional 400 shares during the last quarter. Cubist Systematic Strategies LLC boosted its position in shares of LHC Group by 758.0% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock valued at $116,000 after acquiring an additional 1,516 shares during the last quarter. First Mercantile Trust Co. bought a new position in shares of LHC Group during the 2nd quarter valued at approximately $147,000. Finally, Invictus RG bought a new position in shares of LHC Group during the 1st quarter valued at approximately $125,000. Hedge funds and other institutional investors own 85.93% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.